Will Sanofi's Wonder Drug Save the Day?

Its multitask drug Acomplia is aimed at helping people lose weight, control cholesterol, and even stop smoking. And it comes at a crucial time

On Nov. 20, the U.S. government awarded Sanofi-Aventis a $118 million contract to supply 3.7 million doses of its new bird-flu vaccine. For the world's third largest drugmaker, it's a rare bit of good news in an otherwise difficult year.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.